Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
Item 1.01
The filing discloses a private placement of 1,470,588 unregistered ADSs (or prefunded warrants) representing 80,000 ordinary shares per ADS, together with Series H, I, and J warrants. This is a classic dilutive equity issuance to raise capital. The amendment consolidates the second and third closing dates into a single combined closing on June 26, 2026, with the remaining 980,395 ADSs delivered on that date. The unregistered nature and warrant components are hallmarks of a dilutive capital raise at a small-cap biotech company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
TEN Holdings announced a registered direct offering of 7.5 million shares of common stock at $1.00 per share, generating approximately $7.5 million in gross proceeds. Item 1.01 discloses entry into a Placement Agency Agreement with WestPark Capital, Inc. as the exclusive placement agent. This is a registered equity issuance that will dilute existing shareholders and is material to investors assessing the company's capital structure and ownership stakes.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-26
Item 3.02
The Company issued 86,583 shares of common stock in exchange for preferred stock held by an existing investor, relying on Section 3(a)(9) of the Securities Act. This is an unregistered equity issuance that increases the common share count without cash proceeds, which is dilutive to existing shareholders. The transaction is material as it affects the capital structure and ownership percentages of the registrant.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-26
Item 3.02
New Mountain Private Credit Fund completed an unregistered sale of 2,147 common shares of beneficial interest under Section 4(a)(2) and Regulation D Rule 506, representing a private placement exempt from Securities Act registration.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-26
WF International disclosed a private placement of 1,680,671 ordinary shares at $1.19 per share for $2,000,000 aggregate proceeds under Regulation S, executed June 24, 2026. This is an unregistered equity issuance that dilutes existing shareholders. The filing also discloses a waiver agreement under which the Company paid $80,000 cash and 20,000 shares to placement agents and reduced warrant exercise prices from $25.00 and $3.8671 to $1.19 per share, further diluting shareholder value. These transactions are material capital-raising events typical of small-cap issuers.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
Item 3.02
The Company sold 767,953 shares of common stock pursuant to an unregistered Securities Purchase Agreement with C/M Capital Master Fund, LP for $117,036 gross proceeds. The disclosure explicitly cites Section 4(a)(2) and Rule 506(b) exemptions, and notes that the purchaser's resales were registered on Form S-1, indicating a private placement with subsequent registration rights—a classic dilutive issuance structure. This is material to investors as it represents significant equity dilution and capital raising activity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Lord Abbett Private Credit Fund issued approximately 231,222 common shares for $5.7 million to accredited investors pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D exemptions. This unregistered private placement materially affects shareholder ownership and the fund's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
The fund issued approximately 137,784 common shares for $3.4 million to accredited investors pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
DEFSEC announced a registered direct offering of 673,006 common shares at CAD$3.74 per share (gross proceeds ~CAD$2.5 million) plus concurrent unregistered warrants to purchase an additional 673,006 shares. This is a dilutive equity issuance raising capital through a registered offering and private placement, which materially affects existing shareholders' ownership percentage and is a key financing event for a small-cap company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 7.01
AMC completed a registered direct offering of 95,250,000 shares of common stock for approximately $200 million in gross proceeds on June 24, 2026, pursuant to a shelf registration statement. The proceeds are earmarked for redemption of $125.5 million in 6.125% Senior Subordinated Notes due 2027 and capital investments.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
ProQR announced the pricing of an underwritten registered direct offering of 27.6 million ordinary shares at $1.81 per share for ~$50 million gross proceeds, plus a concurrent private placement of 5.1 million shares to Eli Lilly for ~$9.2 million. This is a material equity issuance that dilutes existing shareholders and raises capital through unregistered (private placement) and registered direct offerings, fitting the dilutive_issuance category. The concurrent private placement to Lilly is explicitly noted as exempt from registration under Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-25
Item 3.02
BlackRock Private Credit Fund completed an unregistered private placement of 183,697.592 Institutional Class Shares for $4,345,329.81 to feeder vehicles, exempt under Section 4(a)(2) and Regulation S. This represents a significant capital raise and dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 1.01
REalloys entered into a Securities Purchase Agreement on June 24, 2026, to issue approximately 7,017,540 shares of common stock in a private placement at $14.25 per share, generating approximately $100 million in gross proceeds. The unregistered shares are being sold to accredited investors under Section 4(a)(2) and Regulation D Rule 506(b), with registration rights agreements and lock-up provisions for officers and directors.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
EShallGo announced a registered direct offering of 454,968 Class A Ordinary Shares at $3.25 per share, raising approximately $1.479 million in gross proceeds. This is a registered equity issuance under a Form F-3 shelf registration statement, which dilutes existing shareholders. The offering is material to investors as it affects share count, ownership percentages, and the company's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-25
Item 8.01
The Company exercised its right to convert Series O Convertible Preferred Stock into common stock at a conversion ratio of 3.209 shares per preferred share, resulting in a material dilutive issuance of common stock that increases outstanding share count and dilutes existing common shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
26North BDC issued approximately 6.3 million shares of common stock on June 24, 2026, generating $156.2 million in gross proceeds pursuant to subscription agreements with investors. The issuance was made under exemptions from Securities Act registration (Section 4(a)(2), Regulation D, and Regulation S), relying on investor representations of accredited status or non-U.S. person status. This is a classic unregistered equity issuance disclosed under Item 3.02, materially dilutive to existing shareholders and a significant capital raise for the BDC.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Silver Point Specialty Lending Fund issued and sold 182,815 unregistered common shares for $5,000,000 pursuant to subscription agreements with shareholders, relying on Section 4(a)(2) of the Securities Act and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 1.01
Taysha entered into an underwriting agreement on June 24, 2026 to issue 32.5 million shares of common stock at $6.00 per share and 833,333 pre-funded warrants at $5.999 per warrant in a registered public offering, with expected net proceeds of approximately $187.4 million (or $215.6 million with full exercise of the underwriters' 30-day option). The offering is expected to fund operations into the second half of 2028.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
In connection with the convertible notes offering, Ligand issued warrants to purchase up to approximately 4.19 million shares of common stock, and the convertible notes may result in the issuance of up to 2.67 million shares upon conversion, representing a material dilutive capital raise through unregistered securities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
In connection with the business combination, unregistered equity securities were issued including PIPE shares and contingent earnout shares (up to 6,000,000 shares) to Teamshares stockholders and optionholders, issued in reliance on Section 4(a)(2) exemption.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Apollo Infrastructure Company LLC issued and sold approximately $35.5 million in unregistered equity securities across multiple share classes (Series I and Series II A-II, F-I, and I Shares) to third-party investors as of June 1, 2026, under Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Apollo Asset Backed Credit Company LLC completed unregistered sales of equity securities totaling approximately $49.1 million across Series I and Series II share classes to third-party investors as of June 1, 2026, exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S. The issuance of over 1.9 million shares across multiple series represents material capital raising activity that dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 1.01
MoonLake entered into an underwriting agreement on June 23, 2026 to conduct a public offering of 9,000,000 Class A ordinary shares at $20.00 per share, plus pre-funded warrants and an option for underwriters to purchase an additional 1,500,000 shares. The offering is expected to generate approximately $200 million in gross proceeds. This is a material dilutive equity issuance that would significantly affect shareholder ownership percentages and is disclosed under Item 1.01 as a material definitive agreement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-25
Item 8.01
Zoomcar announced an extension of its warrant-for-common-stock exchange offer, which involves converting outstanding warrants into shares of common stock. This is a dilutive capital transaction that increases the share count and requires stockholder approval to increase authorized shares. While the core event is a warrant exchange rather than a new issuance, the economic effect—dilution of existing shareholders through warrant conversion—aligns with dilutive_issuance. The extension itself is administrative, but the underlying offer materially affects capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-25
Item 8.01
The Company consummated its initial public offering of 25,000,000 Class A ordinary shares at $10.00 per share, generating $250,000,000 in gross proceeds, simultaneously with a private placement of 600,000 Class A ordinary shares to the Sponsor for $6,000,000. This is a material capital-raising event involving the issuance of equity securities to the public and a sponsor, typical of a special purpose acquisition company (SPAC) IPO structure. While the filing emphasizes the trust account mechanism and business combination intent rather than immediate dilution to existing shareholders (as this is an IPO with no prior public shareholders), the event represents a substantial dilutive issuance of equity that would materially affect a reasonable investor's assessment of the registrant's capital structure and future ownership.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
The filing discloses a private placement completed on June 18, 2026, under Item 3.02 (Unregistered Sales of Equity Securities). The Company issued 15,000,000 shares of common stock to accredited investors for approximately $3,750,000 in gross proceeds, relying on Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. This is a classic dilutive equity issuance that would materially affect investor assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
DEFSEC announced a registered direct offering of 673,006 common shares at CAD$3.74 per share (raising approximately CAD$2.5 million) plus concurrent unregistered warrants to purchase an additional 673,006 shares. The unregistered warrants are offered under Section 4(a)(2) and Regulation D, constituting a private placement of equity securities that will dilute existing shareholders. This is a classic dilutive issuance combining registered and unregistered equity components.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
On June 19, 2026, the Company sold 14,000 shares of common stock to accredited investors for $70,000 ($5.00 per share) in a private placement exempt under Section 4(a)(2) and Regulation D Rule 506, and granted warrants exercisable for up to 657,876 shares to prior investors. These unregistered equity issuances materially dilute existing shareholders and create registration rights obligations.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-06-25
EX-99.1
The exhibit discloses multiple equity issuances and dilutive transactions: a CAD $2M convertible debenture financing (convertible at $0.06/unit with warrants), a private placement of 7.1M units at $0.07/unit, stock option grants totaling 6.75M shares, and warrant extensions. The convertible debenture and private placement are the primary material events, representing significant capital raises through dilutive securities. While the exhibit also covers warrant extensions and executive appointments, the dominant disclosure is the equity financing activity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
The Company completed an unregistered private placement of 357,143 shares of common stock and warrants to purchase 535,715 additional shares to The Aeon Group, Inc. for $75,000 in the initial tranche, with plans to raise up to $750,000 total under Section 4(a)(2) exemption.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-25
Item 3.02
The Company issued unregistered equity securities (Advisory Fee Shares) to Hivemind Capital Partners under Section 4(a)(2) and Regulation D Rule 506(b) as compensation under the advisory services agreement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-25
Item 3.02
ASP Isotopes Inc. is conducting an unregistered sale of equity securities (Units and Pre-Funded Warrants) under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, with Class A Units to be issued upon exercise of Pre-Funded Warrants, representing a dilutive equity issuance to raise capital as part of the merger transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-25
DSS entered into a securities purchase agreement with Alset on June 23, 2026, receiving a $1,000,000 loan in exchange for a convertible promissory note convertible at $0.45/share and warrants to purchase 17,777,776 shares at $0.50/share. This is a dilutive issuance of equity securities (convertible debt and warrants) in a private placement context, materially affecting shareholder equity and voting power. The transaction is also a related-party transaction requiring stockholder approval, heightening its materiality.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-06-25
The Company issued 100,000 Class B ordinary shares (33,881 shares to settle a $33,000 debt with Ms. Liu, the CEO/Chairwoman, plus 66,119 shares sold to her controlled entity Gracedan Co., Limited) at $0.974 per share on June 24, 2026, pursuant to Section 4(a)(2) exemption. This is an unregistered private placement of equity securities that dilutes existing shareholders and raises capital through issuance to an insider-controlled entity.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
DCX announced entry into a securities purchase agreement for a private placement of US$700 million of units, each consisting of one Class A ordinary share and three warrants. This is an unregistered equity issuance to raise capital, fitting the definition of dilutive_issuance. The magnitude ($700M) and the explicit mention of share issuance and warrant exercise rights make this material to investors assessing the company's capital structure and ownership dilution.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
This press release announces a private placement of 1,562,500 ordinary shares (or pre-funded warrants) and accompanying ordinary warrants for $7.5 million gross proceeds. The securities are being sold under Section 4(a)(2) and Regulation D exemptions, representing an unregistered equity issuance. The dilutive nature is material to investors as it increases share count and represents a significant capital raise for the company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-25
Item 1.01
Aether Holdings entered into an At The Market (ATM) Offering Agreement on June 25, 2026, authorizing the sale of up to $10,998,532 of common stock shares through a sales agent. ATM offerings are a form of registered equity issuance that can be dilutive to existing shareholders. The filing explicitly references the Securities Act registration statement and prospectus supplement, confirming this is a registered public offering of equity securities that would materially affect investor assessment of share dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Ares Sports, Media & Entertainment Opportunities LP completed an unregistered private placement of approximately $34.2 million in limited partnership units across multiple unit classes (Class S, Class I, Class A-S, Class A-D, and Class A-I) to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Beyond Meat entered into warrant agreements with Big Geyser on June 22, 2026, granting rights to purchase up to 4,166,667 shares of common stock at exercise prices of $0.60 and $0.001 per share through a private placement relying on Section 4(a)(2) exemption. The warrants feature weighted average anti-dilution provisions and net-share settlement options, representing a dilutive equity financing arrangement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
VisionWave issued 1,331,637 shares of common stock to SaverOne as consideration under an Exchange Agreement, with aggregate value of approximately $4.26 million across two closings, in reliance on Section 4(a)(2) and Rule 506(b) exemptions as an unregistered private placement to an accredited investor.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
This press release announces the closing of a US$50 million underwritten public offering of 10,309,280 common shares at US$4.85 per share. The offering was conducted pursuant to a prospectus supplement and Form F-10 registration statement filed with the SEC, representing a material dilutive issuance of equity securities. The proceeds are earmarked for clinical development programs and working capital, making this a significant capital-raising event for the clinical-stage pharmaceutical company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-25
Item 5.03
The Company filed a Certificate of Designation on June 24, 2026, creating 150,000 shares of Series B Convertible Preferred Stock with a conversion price of $1.25 per share, following stockholder approval on June 23, 2026. The Series B Preferred Stock is convertible into Common Stock and represents a dilutive issuance to Omnia pursuant to the Omnia Venture Agreements.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-24
EX-99.1
Cybin Inc. announced an underwritten public offering of 10,309,280 common shares at US$4.85 per share for aggregate gross proceeds of US$50 million, underwritten by Cantor and Barclays, with expected closing on June 25, 2026, subject to customary closing conditions and regulatory approvals.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-24
Item 7.01
Hertz announced a $100 million registered public offering of common stock to be loaned to J.P. Morgan Securities LLC for short-sale hedging by note investors, creating material economic dilution to existing shareholders through the short-sale mechanism.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 1.01
uniQure entered into an underwriting agreement on June 23, 2026 for a registered public offering of 4,945,055 ordinary shares at $45.50 per share, with underwriters granted a 30-day option to purchase an additional 741,758 shares (exercised in full on June 24, 2026), expected to generate approximately $225 million in gross proceeds and materially dilute existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 1.01
Definium entered into an underwriting agreement on June 23, 2026 for a public offering of 20,588,236 common shares at $34.00 per share, with underwriters exercising their full option for an additional 3,088,235 shares, generating approximately $805 million in gross proceeds. This registered public offering will dilute existing shareholders materially.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-24
Item 8.01
The filing discloses an ongoing private placement offering of up to $2.165 billion of common shares across multiple classes, with $534.084 million already raised as of May 31, 2026. This represents a substantial unregistered equity issuance that would dilute existing shareholders. While the filing also mentions dividend declarations and DRIP activity, the primary material event disclosed in Item 8.01 is the status and scale of the continuous private offering, which is a classic dilutive issuance event material to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 1.01
Absci entered into an underwriting agreement on June 24, 2026 to issue 13,495,277 shares of common stock at $7.41 per share, generating approximately $100 million in gross proceeds ($93.5 million net) pursuant to an effective Form S-3 shelf registration statement. The offering includes participation from strategic investors including Eli Lilly & Company and materially dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
The Fund disclosed an unregistered sale of LLC units (equity securities) for $66.97 million pursuant to a capital call notice delivered to investors on June 22, 2026. The issuance is exempt under Section 4(a)(2) and Regulation D, which are hallmarks of private placements. This is a material capital raise that increases the Fund's equity base and dilutes existing unit holders' ownership percentages.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
Fortress Private Lending Fund completed an unregistered sale of 182,155 Class I common shares for $4.4 million to accredited investors under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →